Skip to content

What Is Innovation? The Architecture of Radical Preference

Key Takeaways
  • Beyond the Gadget: Why innovation is never about technology for its own sake, but about the “drug-delivery” of preference.
  • The Business Art Standard: How to treat your GTM strategy as a “galleriable” artifact rather than a spreadsheet exercise.
  • De-Risking the New: Moving from “Scaling the Beta” to an “Investable Proposition” that ensures your board says yes.

About the Author: This expert insight was authored by Kevin Hartley, the “Architect of Preference” with over 30 years of experience building billion-dollar brands. As the founder of Green Mountain Energy and former Chief Innovation Officer at Keurig, Kevin is the creator of The Rx of Preference. With 15+ patents and a legacy of $14B in value creation, Kevin specializes in replacing “pleasure-agnostic” strategies with the biology of business.

Table of Contents

I have spent thirty years navigating the highest levels of business, split evenly between fifteen years as a serial entrepreneur and fifteen years in the Fortune 500 C-suite. From leading the marketing strategy that took Green Mountain Energy to a $100 million exit to serving as the Chief Innovation Officer at Keurig, I have lived the definition of innovation from every angle.

The candid truth is that most Board Chairs and CEOs treat “innovation” as a department or a line item. They think it’s about R&D labs or buying the latest AI software. That is a fundamental misunderstanding of the game. Innovation is actually the practice of Business Art—the intentional creation of a product or service that triggers a total pleasure-chemical takeover in your customer’s brain.

By the time you finish this article, you will stop viewing innovation as a risk and start viewing it as the architecture of desire. I am going to show you how to use the Rx of Preference to turn raw ideas into world-class outcomes.

Innovation Is a Drug-Delivery Business

If you aren’t triggering dopamine, you aren’t innovating. You are just iterating. Most companies spend millions “Scaling the Beta”—rushing a slightly better version of a mediocre product into the wild. That isn’t innovation; that’s just making a faster horse.

The 200,000-Year-Old Secret

Our brains are hardwired by 200,000 years of evolution to move toward pleasure and away from pain. True innovation identifies a specific “pain point” (cortisol) and replaces it with a “totally smokingly cool” solution (dopamine).

When I helped scale Keurig, we weren’t just selling coffee machines. We were innovating the ritual. We removed the pain of the messy pot and replaced it with the immediate, endorphin-rich satisfaction of a perfect cup in sixty seconds. That is the biological definition of innovation.

The Three Creations of a Master Architect

Innovation doesn’t stop at the product. To be a “Hybrid” leader, you must realize that you are building three distinct things at once. I call these the Three Creations.

1. The Product That Sells

This is your “Business Art.” It must be so well-considered, so intuitive, and so beautiful that it feels galleriable. If it doesn’t stand out as a piece of art, it’s just another commodity waiting to be undercut on price.

2. The Org That Delivers

Innovation fails if your culture is toxic. You must hire “Genuine Big Hearts” who are whip-smart and insatiably curious. Without the right culture, your most innovative ideas will be cut down by “Tall Poppy Syndrome” before they ever reach the customer.

3. The Deployment of Profits

True innovation generates a surplus. How you deploy those profits—balancing the Triple Bottom Line of people, planet, and profit—is the final act of the innovative process.

Wringing Out the Risk: The Investable Proposition

The reason most “Rising Executives” fail to get their innovative ideas funded is that they don’t present an Investable Proposition. They ask for too much capital too early, triggering the board’s amygdala (fear).

The “Last Experiment First” Strategy

Innovation is not a blind leap. It’s a series of de-risked tranches. I always advise my teams to run the “Last Experiment First.”

Don’t spend $10 million building the factory. Spend $100,000 building a high-fidelity mock-up that represents your “smokingly cool” vision. Test the preference architecture first. If the customers don’t have a visceral, chemical reaction to the prototype, the innovation is dead on arrival.

FAQ

Kevin Hartley Headshot

KEVIN HARTLEY

Kevin Hartley is the Architect of Preference, who transforms generic brands into market leaders by installing The Rx of Preference—a biological strategy that diagnoses “pleasure-agnostic” failures and engineers the neurochemistry of scale. Kevin is the Founder of Green Mountain Energy ($110M exit), former Chief Innovation Officer at Keurig ($14B scale), and CEO of Cambio Roasters.